Tony Kong

Ah-Ng Tony Kong is Professor II (Distinguished), Glaxo Chair Professor of Pharmaceutics and Director of the Graduate Program in Pharmaceutical Science at Rutgers, The State University of New Jersey. He is also the Associate Director for the Center for Cancer Prevention Research, a member of the Environmental & Occupational Health Sciences Institute and the Cancer Institute of New Jersey. Dr. Kong received his B.S. in Pharmacy in 1983 from the University of Alberta, Canada and his Ph.D. in Pharmacokinetics and Pharmacodynamics in 1989 from the State University of New York at Buffalo. He received his post-doctoral training in molecular genetics and cellular signaling from 1989-1991 at the National Institutes of Health (NIH). He was on the faculty of Thomas Jefferson University Medical School and the University of Illinois at Chicago before joining Rutgers in early 2001. Dr. Kong continues to serve on the NIH Study Section since 1999 and he has been continued receiving funding support from the NIH since 1993. He has trained more than 30 post-doctoral fellows, visiting professors, Ph.D. and M.S. students. He has published more than 150 original research, review articles and book-chapters. He has chaired and given presentations in many National and International Symposia. He teaches in Pharmacy and Pharmaceutical Sciences, Biopharmaceutics, Pharmacokinetics and Drug Metabolism to the PharmD and Ph.D./M.S. Students. He is an Editor of Pharmaceutical Research, North America Editor of Acta Pharmacologica Sinica and member of editorial advisory boards of Biopharmaceutics and Drug Disposition and Cancer Prevention Research (AACR). His research areas are in dietary phytochemicals (signaling and gene expression, nutrigenomics, cancer chemoprevention), animal tumor models of prostate, colon and skin, epigenetics, oxidative/redox/inflammatory stress response and Nrf2-mediated nuclear transactivation & signaling, pharmacokinetics, pharmacodynamics, pharmacogenetics and individualized/personalized medicine.